本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

14.30
+0.10500.74%
成交量:17.28萬
成交額:245.93萬
市值:17.14億
市盈率:-19.25
高:14.34
開:14.22
低:14.10
收:14.19
52周最高:17.75
52周最低:8.03
股本:1.20億
流通股本:8,653.40萬
量比:0.52
換手率:0.20%
股息:- -
股息率:- -
每股收益(TTM):-0.7427
每股收益(LYR):-1.1578
淨資產收益率:-57.33%
總資產收益率:-13.46%
市淨率:12.33
市盈率(LYR):-12.35

資料載入中...

2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/17

重要事件披露

Form 8-K - Current report
2025/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/06

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]